Subthreshold Micropulse Diode Laser Treatment in Diabetic Macular Oedema

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 2004 Aug 20

PMID 15317711

Citations 67

Authors

M L Laursen

F Moeller

B Sander

A K Sjoelie

Affiliations

Soon will be listed here.

Abstract

Background/aim: Enlargement of laser scars after retinal argon laser photocoagulation can give rise to deterioration in visual acuity. Subthreshold micropulse diode laser may decrease this risk. The aim of this study was to compare the effectiveness of subthreshold micropulse diode laser (810 nm) and conventional argon laser (514 nm) photocoagulation for the treatment of clinically significant macular oedema in diabetic patients.

Methods: 23 eyes of 16 patients were randomised to either treatment. Follow up was conducted for a minimum of 5 months. Changes in visual acuity and macular oedema measured by optical coherence tomography were examined.

Results: Visual acuity remained stable in all treatment groups throughout the observation period. Changes in retinal thickness were small both foveally and perifoveally. In patients with focal macular oedema a significant reduction in retinal thickness (9% approximately -26 microm, p = 0.02) was seen foveally 3 months after diode laser photocoagulation.

Conclusion: Subthreshold micropulse diode laser and conventional argon laser treatment showed an equally good effect on visual acuity. Subthreshold micropulse diode laser showed a stabilising or even improving effect on macular oedema. The combination of primary diode laser and supplementary argon laser might be particularly favourable in reducing diabetic macular oedema.

Citing Articles

Settings and Clinical Applications of Subthreshold Micropulse Laser Therapy: A Review.

Sorrentino T, Allegrini D, De Rosa G, Santoru F, Crepaldi L, Feo A J Clin Med. 2024; 13(19).

PMID: 39407788 PMC: 11477394. DOI: 10.3390/jcm13195729.

Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion.

Scott I, Oden N, Ip M, VanVeldhuisen P, Blodi B Am J Ophthalmol. 2024; 266:110-117.

PMID: 38705553 PMC: 11402581. DOI: 10.1016/j.ajo.2024.04.027.

Subthreshold micropulse laser combined with anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis.

Hosoya H, Ueta T, Hirasawa K, Toyama T, Shiraya T Graefes Arch Clin Exp Ophthalmol. 2024; 262(10):3073-3083.

PMID: 38662102 PMC: 11458775. DOI: 10.1007/s00417-024-06460-7.

Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligence.

Dogan M, Bilgin A, Sari R, Bulut M, Akar Y, Aydemir M Eye (Lond). 2024; 38(9):1694-1701.

PMID: 38467864 PMC: 11156854. DOI: 10.1038/s41433-024-03000-9.

Subthreshold micropulse laser therapy for early postoperative macular thickening following surgical removal of epiretinal membrane.

Lin H, Huang Z, Huang D, Zheng D, Lin P, Lin Y BMC Ophthalmol. 2024; 24(1):102.

PMID: 38443874 PMC: 11391687. DOI: 10.1186/s12886-024-03365-1.

References

Olk R . Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1990; 97(9):1101-12; discussion 1112-3. DOI: 10.1016/s0161-6420(90)32449-1. View

Lewis H, Schachat A, Haimann M, Haller J, Quinlan P, von Fricken M . Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology. 1990; 97(4):503-10; discussion 510-1. DOI: 10.1016/s0161-6420(90)32574-5. View

Han D, Mieler W, Burton T . Submacular fibrosis after photocoagulation for diabetic macular edema. Am J Ophthalmol. 1992; 113(5):513-21. DOI: 10.1016/s0002-9394(14)74722-1. View

Guyer D, DAmico D, Smith C . Subretinal fibrosis after laser photocoagulation for diabetic macular edema. Am J Ophthalmol. 1992; 113(6):652-6. DOI: 10.1016/s0002-9394(14)74789-0. View

Rutledge B, Wallow I, Poulsen G . Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema. Arch Ophthalmol. 1993; 111(5):608-13. DOI: 10.1001/archopht.1993.01090050042025. View

Ulbig M, McHugh D, Hamilton A . Diode laser photocoagulation for diabetic macular oedema. Br J Ophthalmol. 1995; 79(4):318-21. PMC: 505092. DOI: 10.1136/bjo.79.4.318. View

Hee M, Puliafito C, Wong C, Duker J, Reichel E, Rutledge B . Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995; 113(8):1019-29. DOI: 10.1001/archopht.1995.01100080071031. View

Fong D, Segal P, Myers F, Ferris F, Hubbard L, Davis M . Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1997; 115(7):873-7. DOI: 10.1001/archopht.1997.01100160043006. View

Akduman L, Olk R . Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1997; 104(9):1433-41. DOI: 10.1016/s0161-6420(97)30119-5. View

10.

Friberg T, Karatza E . The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997; 104(12):2030-8. DOI: 10.1016/s0161-6420(97)30061-x. View

11.

Hee M, Puliafito C, Duker J, Reichel E, Coker J, WILKINS J . Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998; 105(2):360-70. PMC: 2923575. DOI: 10.1016/s0161-6420(98)93601-6. View

12.

Akduman L, Olk R . Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME). Ophthalmic Surg Lasers. 1999; 30(9):706-14. View

13.

Antcliff R, Stanford M, Chauhan D, Graham E, Spalton D, Shilling J . Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology. 2000; 107(3):593-9. DOI: 10.1016/s0161-6420(99)00087-1. View

14.

Mainster M . Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol. 2000; 14(4):200-9. DOI: 10.3109/08820539909069538. View

15.

Rivellese M, George A, Sulkes D, Reichel E, Puliafito C . Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Ophthalmic Surg Lasers. 2000; 31(3):192-7. View

16.

Lovestam-Adrian M, Agardh E . Photocoagulation of diabetic macular oedema--complications and visual outcome. Acta Ophthalmol Scand. 2001; 78(6):667-71. DOI: 10.1034/j.1600-0420.2000.078006667.x. View

17.

Yang C, Cheng C, Lee F, Hsu W, Liu J . Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand. 2001; 79(3):266-70. DOI: 10.1034/j.1600-0420.2001.790311.x. View

18.

Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A . Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol. 2001; 119(8):1135-42. DOI: 10.1001/archopht.119.8.1135. View

19.

Gupta V, Gupta A, Kaur R, Narang S, Dogra M . Efficacy of various laser wavelengths in the treatment of clinically significant macular edema in diabetics. Ophthalmic Surg Lasers. 2001; 32(5):397-405. View

20.

Goebel W . Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina. 2002; 22(6):759-67. DOI: 10.1097/00006982-200212000-00012. View